World Journal of Gastroenterology
暂无分享,去创建一个
T. Proverbs-Singh | Ishan Jani | Weissman | Hirra Khalid | Parvathy Suresh | J. Moore | Ayrton I Bangolo | Chinmay Trivedi | Karamvir Randhawa | Silvanna Pender | Budoor Alqinai | Alina Intisar | Shaji Faisal | Nicoleta de Deugd | Suchith Boodgere | Vignesh K Gopani | Tracy Nagesh | Simcha Proverbs-Singh | Simcha Nagesh
[1] Biao Yang,et al. T cells in pancreatic cancer stroma: Tryptophan metabolism plays an important role in immunoregulation , 2023, World journal of gastroenterology.
[2] Qijiang Mao,et al. Microbiota Regulates Pancreatic Cancer Carcinogenesis through Altered Immune Response , 2023, Microorganisms.
[3] C. Figueiredo,et al. Harnessing the Microbiome to Reduce Pancreatic Cancer Burden , 2023, Cancers.
[4] D. Daley,et al. The Gut Microbiome and Pancreatic Cancer Development and Treatment , 2023, Cancer journal.
[5] Victor G. Puelles,et al. Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer , 2023, Nature.
[6] A. Gasbarrini,et al. Pancreatic Cancer Resistance to Treatment: The Role of Microbiota , 2023, Biomedicines.
[7] A. Cucchetti,et al. Microbiota in the Natural History of Pancreatic Cancer: From Predisposition to Therapy , 2022, Cancers.
[8] C. Dang,et al. The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer , 2022, Science Immunology.
[9] Xiaopeng Chen,et al. microRNA-497 prevents pancreatic cancer stem cell gemcitabine resistance, migration, and invasion by directly targeting nuclear factor kappa B 1 , 2022, Aging.
[10] Xiaoxue Zhou,et al. Microbiota in Tumors: From Understanding to Application , 2022, Advanced science.
[11] M. Malafa,et al. Pancreatic Ductal Carcinoma Risk Associated With Hereditary Cancer-Risk Genes , 2022, Journal of the National Cancer Institute.
[12] S. Hecht,et al. Metabolic Activation and DNA Interactions of Carcinogenic N-Nitrosamines to Which Humans Are Commonly Exposed , 2022, International journal of molecular sciences.
[13] C. Guinane,et al. The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development , 2022, BMC microbiology.
[14] E. Giovannetti,et al. A Comprehensive Review of the Current and Future Role of the Microbiome in Pancreatic Ductal Adenocarcinoma , 2022, Cancers.
[15] E. Stachowska,et al. Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations , 2021, Nutrients.
[16] S. Gea-Sorlí,et al. Inhibition of miR-222 by Oncolytic Adenovirus-Encoded miRNA Sponges Promotes Viral Oncolysis and Elicits Antitumor Effects in Pancreatic Cancer Models , 2021, Cancers.
[17] B. Nelson,et al. CEACAM7 Is an Effective Target for CAR T-cell Therapy of Pancreatic Ductal Adenocarcinoma , 2021, Clinical Cancer Research.
[18] V. Pazienza,et al. High Levels of Prebiotic Resistant Starch in Diet Modulate a Specific Pattern of miRNAs Expression Profile Associated to a Better Overall Survival in Pancreatic Cancer , 2020, Biomolecules.
[19] W. Fisher,et al. Microbiome changes associated with acute and chronic pancreatitis: A systematic review. , 2020, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[20] Shruti S Sawant,et al. Microbes as Medicines: Harnessing the Power of Bacteria in Advancing Cancer Treatment , 2020, International journal of molecular sciences.
[21] G. Nussbaum,et al. Intracellular Porphyromonas gingivalis Promotes the Tumorigenic Behavior of Pancreatic Carcinoma Cells , 2020, Cancers.
[22] D. Metz,et al. The association of Helicobacter pylori with pancreatic cancer , 2020, GastroHep.
[23] Noam Shental,et al. The human tumor microbiome is composed of tumor type–specific intracellular bacteria , 2020, Science.
[24] F. He,et al. [Effects of Akkermansia muciniphila on the Proliferation, Apoptosis and Insulin Secretion of Rat Islet Cell Tumor Cells]. , 2020, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.
[25] C. Xiong,et al. Mechanisms of Oral Bacterial Virulence Factors in Pancreatic Cancer , 2019, Front. Cell. Infect. Microbiol..
[26] J. Shim,et al. Microbial Metabolites Determine Host Health and the Status of Some Diseases , 2019, International journal of molecular sciences.
[27] Z. Karányi,et al. Lithocholic Acid, a Metabolite of the Microbiome, Increases Oxidative Stress in Breast Cancer , 2019, Cancers.
[28] Christine B. Peterson,et al. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes , 2019, Cell.
[29] Zhuling Yang,et al. Expression of FXR and HRG and their clinicopathological significance in benign and malignant pancreatic lesions. , 2019, International journal of clinical and experimental pathology.
[30] Xianjun Yu,et al. The microbiota and microbiome in pancreatic cancer: more influential than expected , 2019, Molecular cancer.
[31] M. Inoue,et al. Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study , 2019, Scientific Reports.
[32] B. Helmink,et al. The microbiome, cancer, and cancer therapy , 2019, Nature Medicine.
[33] H. Eguchi,et al. Possible involvement of Enterococcus infection in the pathogenesis of chronic pancreatitis and cancer. , 2018, Biochemical and biophysical research communications.
[34] N. Merchant,et al. Microbial Dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer , 2018, bioRxiv.
[35] J. Goedert,et al. Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness. , 2018, Biochimica et biophysica acta. Bioenergetics.
[36] Y. Yamaoka,et al. Aggregatibacter actinomycetemcomitans infection causes DNA double‐strand breaks in host cells , 2018, Genes to cells : devoted to molecular & cellular mechanisms.
[37] G. Jenkins,et al. Comparison of the composition of bile acids in bile of patients with adenocarcinoma of the pancreas and benign disease , 2017, The Journal of Steroid Biochemistry and Molecular Biology.
[38] Noam Shental,et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine , 2017, Science.
[39] S. Amar,et al. Periodontal disease, edentulism, and pancreatic cancer: a meta-analysis , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[40] R. Hayes,et al. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study , 2016, Gut.
[41] Qi Zhang,et al. The hepatitis B virus X protein promotes pancreatic cancer through modulation of the PI3K/AKT signaling pathway. , 2016, Cancer letters.
[42] A. Khorana,et al. Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] Hui-Yi Feng,et al. Role of bile acids in carcinogenesis of pancreatic cancer: An old topic with new perspective , 2016, World journal of gastroenterology.
[44] P. Hylemon,et al. Consequences of bile salt biotransformations by intestinal bacteria , 2016, Gut microbes.
[45] Dong Soo Lee,et al. Helicobacter pylori in gastric carcinogenesis. , 2015, World journal of gastrointestinal oncology.
[46] F. Ginhoux,et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota , 2015, Science.
[47] G. Kouraklis,et al. Pregnane X Receptor Expression in Human Pancreatic Adenocarcinoma: Associations With Clinicopathologic Parameters, Tumor Proliferative Capacity, Patients’ Survival, and Retinoid X Receptor Expression , 2015, Pancreas.
[48] S. Jonjić,et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. , 2015, Immunity.
[49] E. Kallay,et al. The vitamin D system is deregulated in pancreatic diseases , 2014, The Journal of Steroid Biochemistry and Molecular Biology.
[50] G. Mirey,et al. The Cytolethal Distending Toxin Effects on Mammalian Cells: A DNA Damage Perspective , 2014, Cells.
[51] Jacques Izard,et al. Microbiota, Oral Microbiome, and Pancreatic Cancer , 2014, Cancer journal.
[52] K. S. Prabhu,et al. The microbiome and obesity-an established risk for certain types of cancer. , 2014, Cancer journal.
[53] Xi Chen,et al. Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids. , 2014, Cancer research.
[54] A. Schieber,et al. The Role of Intestinal Microbiota in Development of Irinotecan Toxicity and in Toxicity Reduction through Dietary Fibres in Rats , 2014, PloS one.
[55] P. Gérard. Metabolism of Cholesterol and Bile Acids by the Gut Microbiota , 2013, Pathogens.
[56] F. Marincola,et al. Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment , 2013, Science.
[57] M. R. Rubinstein,et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. , 2013, Cell host & microbe.
[58] K. Brown,et al. Current trends in preoperative biliary stenting in patients with pancreatic cancer. , 2013, Surgery.
[59] A. Gurney,et al. Canonical wnt signaling is required for pancreatic carcinogenesis. , 2013, Cancer research.
[60] Qiang Feng,et al. A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.
[61] F. Clavel-Chapelon,et al. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study , 2012, Gut.
[62] D. Heron,et al. Adjuvant Stereotactic Body Radiotherapy for Resected Pancreatic Adenocarcinoma with Close or Positive Margins , 2012, Journal of Gastrointestinal Cancer.
[63] T. Mak,et al. Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity , 2011, Proceedings of the National Academy of Sciences.
[64] A. Maitra,et al. Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[65] M. Shoham,et al. Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity , 2011, Molecular microbiology.
[66] V. Lemmens,et al. Improving outcome for patients with pancreatic cancer through centralization , 2011, The British journal of surgery.
[67] P. Woster,et al. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis , 2011, Proceedings of the National Academy of Sciences.
[68] Matthew R. Redinbo,et al. Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme , 2010, Science.
[69] Malte Buchholz,et al. Stromal biology and therapy in pancreatic cancer , 2010, Gut.
[70] F. C. Gibson,et al. Review: Pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways. , 2010, Molecular oral microbiology.
[71] N. Neerchal,et al. Image-Guided Stereotactic Radiosurgery for Locally Advanced Pancreatic Adenocarcinoma Results of First 85 Patients , 2010, Journal of Gastrointestinal Surgery.
[72] Tibor Schuster,et al. Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages , 2010, PLoS medicine.
[73] S. Sørensen,et al. Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults , 2010, PloS one.
[74] D. Gouma,et al. Preoperative biliary drainage for cancer of the head of the pancreas. , 2010, The New England journal of medicine.
[75] E. Díaz-Rubio,et al. Second-line therapy for advanced pancreatic cancer: a review of the literature and future directions. , 2009, Cancer treatment reviews.
[76] R. Hruban,et al. Assessment of “Gene–Environment” Interaction in Cases of Familial and Sporadic Pancreatic Cancer , 2009, Journal of Gastrointestinal Surgery.
[77] Alison P. Klein,et al. Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene , 2009, Science.
[78] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[79] Douglas B. Evans,et al. Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater. , 2008, International journal of radiation oncology, biology, physics.
[80] D. Ankerst,et al. The Role of Adjuvant Chemotherapy for Patients with Resected Pancreatic Cancer: Systematic Review of Randomized Controlled Trials and Meta-Analysis , 2008, Oncology.
[81] P. Murawa,et al. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group , 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[82] A. Yoon,et al. Suicide cancer gene therapy using pore-forming toxin, streptolysin O , 2006, Molecular Cancer Therapeutics.
[83] U. Stenram,et al. Helicobacter species ribosomal DNA in the pancreas, stomach and duodenum of pancreatic cancer patients. , 2006, World journal of gastroenterology.
[84] M. Kudo,et al. Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography , 2004, Gut.
[85] H. Friess,et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma , 2004, The British journal of surgery.
[86] Alison P. Klein,et al. Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds , 2004, Cancer Research.
[87] R. Jeffrey,et al. MDCT in Pancreatic adenocarcinoma: prediction of vascular invasion and resectability using a multiphasic technique with curved planar reformations. , 2004, AJR. American journal of roentgenology.
[88] Agneta Richter-Dahlfors,et al. Vesicle-Mediated Export and Assembly of Pore-Forming Oligomers of the Enterobacterial ClyA Cytotoxin , 2003, Cell.
[89] A. Ziegler,et al. BRCA2 germline mutations in familial pancreatic carcinoma. , 2003, Journal of the National Cancer Institute.
[90] R. Jeffrey,et al. Local staging of pancreatic carcinoma with multi-detector row CT: use of curved planar reformations initial experience. , 2002, Radiology.
[91] W. Schima,et al. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT. , 2002, AJR. American journal of roentgenology.
[92] Hong-Jin Kim,et al. Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer? , 2002, Journal of Gastrointestinal Surgery.
[93] S. Rickes,et al. Differentiation of Pancreatic Tumours by Conventional Ultrasound, Unenhanced and Echo-Enhanced Power Doppler Sonography , 2002, Scandinavian journal of gastroenterology.
[94] T. Ichikawa,et al. Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. , 2001, Radiology.
[95] M. Blaser,et al. Helicobacter pylori Seropositivity as a Risk Factor for Pancreatic Cancer , 2001 .
[96] D. Kerr,et al. European Study Group for Pancreatic Cancer‐1 interim results: a European randomized study to assess the roles of adjuvant chemotherapy and chemoradiation in resectable pancreatic cancer , 2001 .
[97] J. Laméris,et al. MRI with mangafodipir trisodium in the detection and staging of pancreatic cancer , 2000, Journal of magnetic resonance imaging : JMRI.
[98] J. Rastad,et al. Abdominal US for diagnosis of pancreatic tumor: prospective cohort analysis. , 1999, Radiology.
[99] Jeffrey E. Lee,et al. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[100] J Coste,et al. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. , 1998, AJR. American journal of roentgenology.
[101] D. V. Von Hoff,et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[102] B. Marincek,et al. Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. , 1994, Radiology.
[103] S. Goodman,et al. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. , 1993, The American journal of pathology.
[104] E. Deitch,et al. Absence of intestinal bile promotes bacterial translocation. , 1992, The American surgeon.
[105] V. Dest,et al. When the diagnosis is pancreatic cancer. , 1991, RN.
[106] S. Ellenberg,et al. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. , 1985, Archives of surgery.
[107] S. Hirano,et al. [Transformation of bile acids by Bacteroides fragilis strains isolated from the human intestine (author's transl)]. , 1979, Nihon saikingaku zasshi. Japanese journal of bacteriology.
[108] H. Kocher,et al. Pancreatic Cancer , 2019, Methods in Molecular Biology.
[109] Hodgkin Lymphoma. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines , 2014 .
[110] E. Diamandis,et al. Pancreatic cancer. , 2013, Clinical chemistry.
[111] Yuchen Jiao,et al. ATM mutations in patients with hereditary pancreatic cancer. , 2012, Cancer discovery.
[112] S. Onda,et al. [Pancreatic carcinoma]. , 2012, Nihon rinsho. Japanese journal of clinical medicine.
[113] C. Catalano,et al. Pancreatic carcinoma: the role of high-resolution multislice spiral CT in the diagnosis and assessment of resectability , 2002, European Radiology.
[114] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[115] D. Roe,et al. Quantitative relationship between oral nitrate-reducing activity and the endogenous formation of N-nitrosoamino acids in humans. , 1991, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[116] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.